256 Newsroom — Uganda's Digital News Infrastructure
Business

Novartis Shares Fall After Heart Drug Misses Target in Late-Stage Trial - WSJ

Published by The Wall Street Journal By Adrià Calatayud · 7 September 2026 at 11:14
Share
Novartis Shares Fall After Heart Drug Misses Target in Late-Stage Trial - WSJ
Image · The Wall Street Journal

What the report says

Shares in Novartis were down 3.2% in European morning trading Monday, reducing year-to-date gains to 14%

Read the full report at The Wall Street Journal →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting

‎Drought effect on regional milk industry as Kenya turns to UgandaThe Independent Uganda The 25 years we were never taught to liveThe Observer 256 Newsroom Kenya halts deportations of foreign small-scale traders - monitor.co.ugDaily Monitor Why Uganda wants private money to help transform farmingThe Observer 256 Newsroom Tension as Koboko, Yumbe dispute Araga boundary - monitor.co.ugDaily Monitor 256 Newsroom KCCA’s revenue bet: Help businesses survive, then tax their growth - Daily MonitorDaily Monitor